期刊文献+

入院血糖水平对脓毒症患者脏器损伤严重程度及预后的影响 被引量:6

Effect of admission blood glucose levels on multiple organ injuries degrees and prognosis in the patients with sepsis
下载PDF
导出
摘要 目的探讨入院血糖水平与脓毒症患者脏器损伤严重程度及预后的相关性。方法 316例首次发生脓毒症患者,根据患者入院时血糖的四分位数6.9、8.5、10.2 mmol/L分为Ⅰ组(n=61)、Ⅱ组(n=82)、Ⅲ组(n=93)及Ⅳ组(n=80)4组,分析各组血糖水平与脏器损伤严重程度及预后的相关性。结果 316例患者中134例出现多脏器损伤,发生率为42.4%,其中99例住院期间30 d内死亡,病死率为31.3%。入院血糖水平、糖尿病史、肌酸激酶同工酶(CK-MB)峰值、APACHEⅡ评分是脓毒症患者脏器损伤严重程度发生的预测因素。随着血糖的增高,30 d内死亡的危险性增大。结论入院血糖水平对脓毒症患者脏器损伤严重程度及预后有一定的预测价值。 Objective To evaluate the relationship between adimission blood glucose levels and multiple organ injuries degrees and prognosis in the patients with sepsis. Methods 316 patients with sepsis occurred for the first time,accord- ing to the admission blood sugar quartile 6.9, 8.5, 10.2 mmol/L of the patients were divided into I group (n=61), the I1 group (n=82), the 11 group (n=93) and 1V group (n=80) 4 groups,the blood glucose levels and visceral injury severity and prognosis of correlation of each group was analyzed. Results 134 cases with multiple organ damage of 316 patients,the incidence rate was 42.4%,among them,99 cases hospitalized during death within 30 d,the fatality rate of 31.3%.Hospital blood sugar level,diabetes history,CK-MB peak,APACHE II score was sepsis patients with visceral in- jury severity of predictors.With the increasing of blood sugar,increase the risk of dying within 30 d. Conclusion Hos- pital blood glucose level is an prognostic faetor for multiple organ injuries degrees and prognosis in the patients with sepsis.
出处 《中国当代医药》 2013年第27期42-44,共3页 China Modern Medicine
关键词 入院血糖 高血糖症 脓毒症 脏器损伤 预后 Admission-blood glucose Hyperglycemia Sepsis Multiple organ injuries Prognosis
  • 相关文献

参考文献11

  • 1Ssekitoleko R,Jacob ST, Banura P,et a/.Hypoglycemia at admission is associated with inhospital mortality in ugandan patients with severesepsis[J].Crit Care Med, 2011,39 (10) : 2271-2276.
  • 2Leonidou L,Michalaki M,Leonardou A,et d.Stress-induced hyper- glycemia in patients with severe sepsis: a compromising factor for survival[J].Am J Med Sei, 2008,336 (6) : 467-471.
  • 3Levy MM,Fink MP,Marshall JC,et a/.2001 SCCMIESICM/ACCP/ATS/ SIS international sepsis definitions conference[J].Cfit Care Med, 2003,31 (4) : 1250-1256.
  • 4Marshall JC,Cook DJ,Chrisou NV,et a/.Muhiple organ dysfunction score :a reliable descriptor of a complex clinical outeome[J].Crit Care Med, 1995,23 (10) : 1638-1652.
  • 5Van Cromphaut SJ,Vanhorebeek I,Van den Berghe G.Glueose metabolism and insulin resistance in sepsis[J].Curr Pharm Des,2008,14(19) : 1887- 1899.
  • 6Calisto KL,Camacho AC,Mittestainer FC,et a/.Diacerhein attenuates the inflammatory response and improves survival in a model of severe sepsis[J].Crit Care, 2012,16 (4) : R158.
  • 7Taegtmeyer H, Mcnulty P,Young ME. Adaptation and maladaptation of the heart in diabetes.part 1 :general concepts[J].Circulation,2002, 105 (14) : 1727-1733.
  • 8Liu SF,Malik AB.NF-kappa B activation as a pathological mecha- nism of septic shock and inflammation[J].Am J Physiol Lung Cell Mol Physiol, 2006,290 ( 4 ) : L622-L645.
  • 9Savioli M,Cugno M,Polli F,et d.Tight glycemic control may favor fibrinolysis in patients with sepsis[J].Crit Care Med,2009,37 (2): 424-431.
  • 10Kubiak BD, Albert SP, Gatto LA ,et a/.A clinically applicable porcine model of septic and ischemia/reperfusion-induced shock and multi- ple organ injury[J].J Surg Res,2011,166( 1 ):e59-69.

同被引文献50

  • 1孙涛,夏世金,张伟,郑松柏.炎性反应与衰老[J].实用老年医学,2013,27(1):79-82. 被引量:6
  • 2罗振中,彭树兰,鲁桂芳.胰岛素强化治疗对脓毒症预后及血清炎症介质水平的影响[J].西部医学,2007,19(3):392-394. 被引量:3
  • 3骆建军,方强,方雪玲,戚晓平,周博武.脓毒症患者肠道黏膜通透性的临床研究[J].中国急救医学,2007,27(9):789-792. 被引量:13
  • 4Leonidou L Michalaki M, Leonardou A, et al. Stress-induced hy- perglycemia in patients with severe sepsis a compromising factor for survival[J]. Am J Med Sci, 2008, 336(6) : 467-471.
  • 5Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference [ J ]. Intensive Care Med, 2001, 29(4): 530-538.
  • 6Buttenschoen K, Radermacher P, Bracht H. Endotoxin elimination in sepsis : physiology and therapeutic application [J]. Langenbecks Arch Surgm, 2010, 395(6): 597-605.
  • 7Antonopoulou A, Giamarellos-Bourboulis EJ. Immunomodu- lation in sepsis state of the art an d future perspective [ J ]. Immunotherapy,2011,3 ( 1 ) : 117-128.
  • 8Levy MM, Fink MP, Marshall JC, et al. SCCM/ESICM/AC- CP/ATS/SIS international sepsis definitions conference[ J]. Intensive Care Med,2001,29 (4) :530-538.
  • 9Hirsch IB, Coviello A, Mazuski J , et al. Intensivinsul in therapy in critically ill patients [ J ]. N Engl J Med, 2002, 346(120) :1586-1588.
  • 10Barkhausen T, Probst C, Hildebrand F, et al. Insulin ther- apy induces changes in the inflammatory response in a mu- rine 2-hitmodel[J]. Injury,2009,40(8) :806-814.

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部